Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Wells Fargo Sticks to Their Hold Rating for Solventum Corporation (SOLV)

Tipranks - Tipranks - Sat Dec 13, 2025

Wells Fargo analyst Vik Chopra maintained a Hold rating on Solventum Corporation today and set a price target of $72.00.

Claim 50% Off TipRanks Premium and Invest with Confidence

Chopra covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, Globus Medical, and Solventum Corporation. According to TipRanks, Chopra has an average return of 8.2% and a 43.90% success rate on recommended stocks.

Solventum Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $89.29.

See the top stocks recommended by analysts >>

Based on Solventum Corporation’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $2.1 billion and a net profit of $1.27 billion. In comparison, last year the company earned a revenue of $2.08 billion and had a net profit of $122 million

Read More on SOLV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).